Athelas

About:

Athelas develops technology to monitor chronically ill patients in their homes.

Website: https://athelas.com/

Twitter/X: athelasdevice

Top Investors: Y Combinator, General Catalyst, Sequoia Capital, Elad Gil, Tribe Capital

Description:

Athelas develops technology to monitor chronically ill patients in their homes. The company has deployed an FDA-cleared blood diagnostic device along with an array of other sensors to manage Blood Pressure, Weight, Glucose, and Medication Adherence.

Total Funding Amount:

$150M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Mountain View, California, United States

Founded Date:

2016-06-01

Contact Email:

contact(AT)athelas.com

Founders:

Deepika Bodapati, Tanay Tandon

Number of Employees:

101-250

Last Funding Date:

2022-01-31

IPO Status:

Private

Industries:

© 2025 bioDAO.ai